Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

C K Lee; R J Simes; C Brown; S Lord; U Wagner; M Plante; I Vergote; C Pisano; G Parma; A Burges; H Bourgeois; T H?gberg; J Bentley; L Angleitner-Boubenizek; A Ferrero; B Richter; H Hirte; V Gebski; J Pfisterer; E Pujade-Lauraine; M Friedlander

首页> 外文期刊>British Journal of Cancer >Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

【24h】

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

机译：预后列线图可预测铂敏感性复发性卵巢癌患者的无进展生存期

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background:Patients with platinum-sensitive recurrent ovarian cancer are a heterogeneous group, and it is not possible to accurately predict the progression-free survival (PFS) in these patients. We developed and validated a nomogram to help improve prediction of PFS in patients treated with platinum-based chemotherapy.

机译：背景：患有铂敏感的复发性卵巢癌的患者属于异质性人群，因此无法准确预测这些患者的无进展生存期（PFS）。我们开发并验证了列线图，以帮助改善接受铂类化学疗法治疗的患者的PFS预测。

著录项

来源
《British Journal of Cancer》 |2011年第8期|共7页
作者
C K Lee; R J Simes; C Brown; S Lord; U Wagner; M Plante; I Vergote; C Pisano; G Parma; A Burges; H Bourgeois; T H?gberg; J Bentley; L Angleitner-Boubenizek; A Ferrero; B Richter; H Hirte; V Gebski; J Pfisterer; E Pujade-Lauraine; M Friedlander;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer [J] . C K Lee, R J Simes, C Brown, British Journal of Cancer . 2011,第8期

机译：预后列线图可预测铂敏感性复发性卵巢癌患者的无进展生存期
2. A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer [J] . LeeC.K., SimesR.J., BrownC., Annals of oncology: official journal of the European Society for Medical Oncology . 2013,第4期

机译：预后列线图可预测铂敏感性复发性卵巢癌患者的总体生存
3. CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer [J] . Jung-Min Lee, Jane B. Trepel, Peter Choyke, Frontiers in Oncology . 2015,第4期

机译：CECs和IL-8具有复发性铂敏感卵巢癌患者的预后和预测效用：生物标志物与奥拉帕里布的随机相位-2试验与反复性铂敏感卵巢癌中的奥拉帕里布相比相关
4. Identification of Several Core Overexpressed MicroRNAs that Could Predict Survival in Patients with Ovarian Cancer [C] . Eskezeia Y. Dessie, David Agustriawan, Ezra B. Wijaya, IEEE International Conference on Bioinformatics and Bioengineering . 2018

机译：鉴定几种核心过度表达微大血管，可预测卵巢癌患者的存活
5. Evaluation of pathologic parameters and published nomograms in predicting non-sentinel lymph node metastases in female breast cancer patients with positive sentinel lymph nodes. [D] . Murch, Lisa Elaine. 2007

机译：在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
6. Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer [O] . C K Lee, R J Simes, C Brown, 2011

机译：预后列线图可预测铂敏感性复发性卵巢癌患者的无进展生存期
7. Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer [O] . Lee, C.K., Simes, R.J., Brown, C., 2011

机译：预后列线图可预测铂敏感性复发性卵巢癌患者的无进展生存期

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅